Theoretical conceptions of intervention research addressing cancer control issues.

cancer complex interventions intervention research prevention program theory

Journal

Health promotion international
ISSN: 1460-2245
Titre abrégé: Health Promot Int
Pays: England
ID NLM: 9008939

Informations de publication

Date de publication:
12 Mar 2021
Historique:
pubmed: 4 4 2020
medline: 29 7 2021
entrez: 4 4 2020
Statut: ppublish

Résumé

Population health intervention research (PHIR) involves the use of scientific methods to produce knowledge about policy and program interventions that operate within or outside of the health sector and have the potential to impact health at the population level. PHIR is a relatively new research field that has gained momentum internationally. When developing PHIR, it is important to have a program theory with the potential to increase intervention success by identifying underlying mechanisms, areas of failure and unintended outcomes. Since 2010, the French National Cancer Institute (Institut National du Cancer-INCa) has supported a national, competitive, dedicated call for proposals in PHIR to tackle cancer control issues. After 5 years of activity, specific analysis of the proposals submitted for funding and/or funded (n = 63) from descriptive and analytic perspectives was called for. Analysis of the data revealed diversity in terms of targeted populations, partnerships engaged and methodological approaches. Projects were more likely to be funded (n = 15) if presented with a robust methodological approach and diversity in methodology, and/or with research objectives at different levels of action. The analysis also revealed that researchers do not explicitly describe theoretical constructs underpinning their interventions to combat cancer. PHIR still needs improvement to better incorporate social, institutional and policy approaches to cancer control. Researchers should apply a theory-driven approach to distinguish between 'program failure' and 'theory failure'. Following up the funded projects will allow successes and failures to be evaluated with respect to the use (or non-use) of theory-driven approaches.

Identifiants

pubmed: 32243507
pii: 5815611
doi: 10.1093/heapro/daaa032
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

206-215

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Auteurs

Cécile-Marie Dupin (CM)

Department for Research in Social and Human Sciences, Public Health and Epidemiology, Institut National du Cancer, Boulogne-Billancourt F-92513, France.
Faculty of Medicine and Nursing Science, Aix Marseille Université, Marseille, F-13000, France.

Carla Estaquio (C)

Department for Research in Social and Human Sciences, Public Health and Epidemiology, Institut National du Cancer, Boulogne-Billancourt F-92513, France.
Strategic Evaluation and Impact Program, Institut National du Cancer, Boulogne-Billancourt F-92513, France.

Hermann Nabi (H)

Department for Research in Social and Human Sciences, Public Health and Epidemiology, Institut National du Cancer, Boulogne-Billancourt F-92513, France.
Axe Oncologie, Centre de Recherche du CHU de Québec, Québec, Canada.
Département de Médecine Sociale et Préventive, Faculté de Médecine, Université Laval, Québec, Canada.
INSERM, Centre for Research in Epidemiology and Population Health, U1018, F-94807 Villejuif, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH